Clinical Trials Browser

Phase NA × Dysuria × 90 days × Clear all

NCT05148156 2026-01-27

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Phase NA Suspended

Prostatic Hyperplasia, Nocturia, Dysuria